Sarcopenia is a multifactorial condition characterized by loss of muscle mass. It poses
significant health risks in older adults worldwide. Both pharmacological and non …

Sarcopenia, the loss of skeletal muscle mass and function with age, was first recognized as
a disease in the International Classification of Diseases, Tenth Revision, Clinical …

Sarcopenia is a comprehensive degenerative disease with the progressive loss of skeletal
muscle mass with age, accompanied by the loss of muscle strength and muscle dysfunction …

Introduction: Sarcopenia, the age-related loss of skeletal muscle mass and function, is a
global health problem that contributes to the development of physical disability, morbidity …

Sarcopenia is the age-related decline in muscle mass and strength and is associated with
increased risk of adverse health outcomes including falls, morbidity, loss of independence …

Sarcopenia is a skeletal muscle disorder characterized by progressive and generalized
decline in muscle mass and function. Although it is mostly known as an age-related disorder …

Sarcopenia is a disease characterized by the progressive loss of skeletal muscle mass and
function that occurs with aging. The progression of sarcopenia is correlated with the onset of …

In addition to the role of skeletal muscle in movement and locomotion, muscle plays a critical
role in a broad array of metabolic processes that can contribute to improved health or risk of …

Sarcopenia of age is prevalent and costly and proven pharmacological interventions are
currently lacking. The pathophysiology of sarcopenia is incompletely understood but …

Sarcopenia refers to the gradual loss of skeletal muscle mass and function along with aging
and is a social burden due to growing healthcare cost associated with a super-aging society …